Literature DB >> 33398430

Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.

Han-Na Kim1, Soo Yeon Lee1, Baek-Hui Kim1, Chung-Yeul Kim1, Aeree Kim1, Hayeon Kim2.   

Abstract

Tumor budding (TB), a histopathological manifestation of epithelial-mesenchymal transition, is an important step in cancer invasion and metastasis development. TB has been considered a strong prognostic indicator in colorectal cancer. The International Tumor Budding Consensus Conference (ITBCC) scoring system is the standardized method used for patient outcome prediction in several human tumors. We investigated the clinicopathological implications and applicability of TB measured using the ITBCC scoring system in gallbladder cancer (GBC). The TB grades assigned to the 78 GBC patients were as follows: Bd1 (low TB), 41 (52.6%) patients; Bd2 (intermediate TB), 22 (28.2%) patients; and Bd3 (high TB), 15 (19.2%) patients. A higher TB grade correlated with a poorer histological differentiation (P < 0.000), higher pT category (P < 0.000), the involvement of surgical resection margin (P = 0.005), presence of nodal metastasis (P < 0.000), lymphatic and venous invasion (P < 0.000), and perineural invasion (P = 0.004). Univariate Cox regression analysis revealed that a poor histological grade, high pT category, lymphatic invasion, perineural invasion, and intermediate to high TB grades were associated with worse 5-year overall survival and disease-free survival. TB was not significantly associated with death or recurrence risk in multivariate Cox analysis. The interobserver agreement of TB grading was substantial. This study is the first to apply the ITBCC scoring system and suggest the prognostic value of TB in GBC.

Entities:  

Keywords:  Epithelial–mesenchymal transition; Gallbladder neoplasms; Prognosis; Tumor budding

Year:  2021        PMID: 33398430     DOI: 10.1007/s00428-020-03012-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  27 in total

Review 1.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Authors:  Jing Yang; Robert A Weinberg
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

2.  Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.

Authors:  Heather Dawson; Francesca Galuppini; Peter Träger; Martin D Berger; Peter Studer; Lukas Brügger; Inti Zlobec; Daniel Inderbitzin; Alessandro Lugli
Journal:  Hum Pathol       Date:  2018-11-11       Impact factor: 3.466

3.  The significance of tumor budding in T1 colorectal carcinoma: the most reliable predictor of lymph node metastasis especially in endoscopically resected T1 colorectal carcinoma.

Authors:  So Jeong Lee; Ahrong Kim; Young Keum Kim; Won Young Park; Hyun Sung Kim; Hong-Jae Jo; Nahmgun Oh; Geum Am Song; Do Youn Park
Journal:  Hum Pathol       Date:  2018-02-13       Impact factor: 3.466

4.  Tumor budding in colorectal carcinoma: An institutional interobserver reliability and prognostic study of colorectal adenocarcinoma cases.

Authors:  Sean Hacking; Mallorie Angert; Cao Jin; Myriam Kline; Neha Gupta; Margaret Cho; Rebecca Thomas; Lili Lee; Hector Chavarria; Mansoor Nasim
Journal:  Ann Diagn Pathol       Date:  2019-11-07       Impact factor: 2.090

5.  Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

Authors:  H Ueno; J Murphy; J R Jass; H Mochizuki; I C Talbot
Journal:  Histopathology       Date:  2002-02       Impact factor: 5.087

6.  Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients.

Authors:  Inti Zlobec; Francesca Molinari; Vittoria Martin; Luca Mazzucchelli; Piercarlo Saletti; Rosangela Trezzi; Sara De Dosso; Tatjana Vlajnic; Milo Frattini; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2010-10-14       Impact factor: 5.742

Review 7.  Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.

Authors:  Alessandro Lugli; Richard Kirsch; Yoichi Ajioka; Fred Bosman; Gieri Cathomas; Heather Dawson; Hala El Zimaity; Jean-François Fléjou; Tine Plato Hansen; Arndt Hartmann; Sanjay Kakar; Cord Langner; Iris Nagtegaal; Giacomo Puppa; Robert Riddell; Ari Ristimäki; Kieran Sheahan; Thomas Smyrk; Kenichi Sugihara; Benoît Terris; Hideki Ueno; Michael Vieth; Inti Zlobec; Phil Quirke
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

8.  Tumour budding as prognostic factor in stage I/II colorectal carcinoma.

Authors:  F Prall; H Nizze; M Barten
Journal:  Histopathology       Date:  2005-07       Impact factor: 5.087

Review 9.  Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.

Authors:  Wei Lu; Yibin Kang
Journal:  Dev Cell       Date:  2019-05-06       Impact factor: 12.270

10.  Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial.

Authors:  Hideki Ueno; Megumi Ishiguro; Eiji Nakatani; Toshiaki Ishikawa; Hiroyuki Uetake; Chu Matsuda; Yoshihiko Nakamoto; Masanori Kotake; Kiyotaka Kurachi; Tomohisa Egawa; Keigo Yasumasa; Kohei Murata; Osamu Ikawa; Seiichi Shinji; Kenta Murotani; Shigeyuki Matsui; Satoshi Teramukai; Naohiro Tomita; Kenichi Sugihara
Journal:  J Clin Oncol       Date:  2019-06-10       Impact factor: 44.544

View more
  2 in total

1.  The Significance of Tumor Budding and Immunohistochemical Axl Expression in Gallbladder Adenocarcinomas

Authors:  Özden Öz; Asuman Argon; Tulu Kebat; Çisem Namlı Akıncı; Özlem Özdemir
Journal:  Balkan Med J       Date:  2022-04-18       Impact factor: 3.570

2.  Tumor budding and fibrotic focus-proposed grading system for tumor budding in invasive carcinoma no special type of the breast.

Authors:  Miyuki Hiratsuka; Takahiro Hasebe; Toshiaki Saeki; Yuki Ichinose; Ayaka Sakakibara; Akihiro Fujimoto; Noriko Wakui; Satomi Shibasaki; Masataka Hirasaki; Masanori Yasuda; Akemi Nukui; Hiroko Shimada; Hideki Yokogawa; Kazuo Matsuura; Takashi Hojo; Akihiko Osaki
Journal:  Virchows Arch       Date:  2022-06-13       Impact factor: 4.535

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.